Financials

  • Market Capitalization 276.65 M
  • Employee 106
  • Founded 2014
  • CEO N/A
  • Website www.zentalis.com
  • Headquarter California, United States
  • FIGI BBG00R2K8TF5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.71
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3379
TRDA
Entrada Therapeutics, Inc. - Common Stock
7.18 USD-1.24%-5.28%+24.22%+3.01%279.57 M USD
3383
SRZN
Surrozen, Inc. - Common Stock
23.28 USD-3.04%-1.10%+18.90%+100.86%273.62 M USD
3400
NMRA
Neumora Therapeutics, Inc. - Common Stock
1.49 USD+0.68%-7.45%-11.83%-14.86%279.96 M USD
3402
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.87 USD+0.62%0.00%+32.34%+61.79%277.63 M USD

Notizie